Both in Biotechnology
Beam Therapeutics vs Vericel
Over the past year BEAM returned +12.3% and VCEL returned +9.7%; their daily moves had a correlation of 0.21.
BEAM +12.3% VCEL +9.7%Growth of $1, one year, split-adjusted
| Metric | BEAM | VCEL |
|---|---|---|
| Price | $27.23 | $40.26 |
| Market cap | $2.81B | $2.06B |
| Today | −5.58% | −6.18% |
| 1 month | +11.6% | +2.1% |
| 6 months | −11.3% | +13.2% |
| Year to date | −1.8% | +11.8% |
| 1 year | +9.9% | +15.4% |
| Revenue growth (YoY) | −94.2% | +22.5% |
| Gross margin | 100.0% | 72.8% |
| Net margin | −25036.3% | 2.8% |
| P/E (TTM) | — | 85.1× |
| Price / sales | 18.0× | 6.7× |
| Net cash | $1.05B | $162.5M |
| Dividend yield | — | — |
| Volatility (60d) | 62.4% | 33.0% |
| Short % of float | 32.0% | 11.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).